PerpEquities

Twist Bioscience Corporation (TWST) balance sheet

NASDAQ · Healthcare · Biotechnology · 979 employees · CEO Emily Marine Leproust

Price
$152.78 -11.92%
Market cap
$10.1B
Enterprise value
$10B
Last report
Q3 '26 filed 2026-08-03
Next report
2026-11-12 EPS est. -$0.38

At the end of Q3 '26 Twist Bioscience Corporation (TWST) held $167M in cash and short-term investments against $93.6M of debt incl. leases. Total assets $672M, total liabilities $227M, shareholders' equity $446M.

Balance sheet

Balance sheetTrendQ4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Assets
Cash & equivalents$286M$266M$243M$239M$226M$221M$210M$201M$183M$149M$123M$117M
Short-term investments$49.9M$44.9M$50M$50.3M$50.1M$49.4M$46.7M$49.4M$49.4M$49.4M$49M$49.4M
Receivables$44.1M$36.6M$37.1M$33M$34.9M$39.3M$49.9M$49.9M$57.3M$50.1M$64.2M$65.8M
Inventory$32.1M$30.9M$30.4M$28.5M$24.1M$23.5M$20.9M$25.9M$28.3M$32.9M$33.5M$35.2M
Other current assets$11.7M$11.7M$11.1M$10.9M$11.4M$11.6M$10.5M$13.2M-$300K$22.9M$54.1M$53.5M
Current assets$424M$390M$372M$362M$347M$345M$338M$340M$333M$304M$323M$321M
Property, plant & equipment (net)$203M$195M$185M$168M$161M$157M$151M$147M$152M$177M$182M$181M
Long-term investments$2.81M$2.85M$6.58M$6.61M$1.53M$4.18M$4.04M$54.3M$58.5M$54.3M$68.1M$70.2M
Goodwill$85.8M$85.8M$85.8M$85.8M$85.8M$85.8M$85.8M$82.2M$82.2M$82.2M$82.2M$82.2M
Intangible assets$54.5M$53.2M$51.9M$14.7M$14.5M$14.2M$14M$13.7M$13.4M$13.2M$13M$12.7M
Other non-current assets$5.68M$5.42M$1.68M$1.51M$4.38M$1.92M$2.17M$6.41M$3.1M$7.12M$7.62M$5.38M
Non-current assets$352M$343M$331M$276M$268M$263M$257M$304M$309M$334M$353M$351M
Total assets$776M$733M$703M$638M$614M$609M$596M$644M$642M$638M$676M$672M
Liabilities
Accounts payable$14.1M$9.26M$7.7M$6.63M$1.63M$7.5M$8.06M$12M$11.1M$12.5M$14.7M$17M
Accrued expenses$25.8M$20.8M$25.2M$31.7M$15.1M$20.1M$19.6M$19.5M$31.3M$18.8M$45.5M$34.9M
Short-term debt$14.9M$14.8M$14.6M$14.6M$0$0$0$0$13.8M$12.2M$0$8.63M
Taxes payable$4.37M$3.2M$2.11M$2.34M$2.73M$3.27M$4.09M$4.25M$0$0$0$0
Deferred revenue$3M$2.64M$2.54M$2.94M$2.13M$1.38M$2.66M$6.32M$6.88M$9.02M$7.1M$6.47M
Other current liabilities$11.2M$14.5M$15.3M$15.6M$34.6M$22.3M$25.4M$29.5M$23.8M$24M$37.3M$45.9M
Current liabilities$73.3M$65.2M$67.5M$73.8M$71M$69.6M$75M$87.1M$91.4M$80.4M$120M$120M
Long-term debt$0$0$0$0$0$0$0$0$61.8M$85.8M$0$0
Lease obligations (non-current)$79.2M$77.1M$74.8M$72.6M$70.2M$67.6M$65.1M$62.6M$61.8M$85.8M$85.4M$85M
Deferred revenue (non-current)$0$0$0$0$0$0$0$0$0$0$15M$0
Other non-current liabilities$475K$475K$421K$597K$407K$15.4M$15.5M$15.7M-$46M-$70.1M$746K$21.5M
Non-current liabilities$79.6M$77.5M$75.2M$73.2M$70.6M$83M$80.5M$78.3M$77.5M$102M$101M$106M
Total liabilities$153M$143M$143M$147M$142M$153M$156M$165M$169M$182M$221M$227M
Equity
Common stock & paid-in capital$0$0$0$0$0$0$0$0$0$0$1K$1K
Retained earnings-$1.03B-$1.08B-$1.12B-$1.21B-$1.24B-$1.27B-$1.31B-$1.29B-$1.32B-$1.35B-$1.39B-$1.43B
Accumulated other comprehensive income-$756K-$565K-$660K-$735K-$522K-$649K-$662K-$864K-$627K-$571K-$639K-$655K
Shareholders' equity$623M$590M$560M$491M$473M$456M$440M$478M$473M$456M$455M$446M
Debt
Total debt (incl. leases)$94.1M$91.9M$89.4M$87.2M$85M$82.6M$80.3M$78.2M$137M$184M$95.8M$93.6M
Net debt (debt - cash)-$192M-$174M-$154M-$152M-$141M-$139M-$130M-$123M-$45.7M$35.3M-$26.8M-$23.8M

Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Cash, investments and debt

quarter ends

The other statements

Sources

Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-Q 2025-12-31, 10-K 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-Q 2024-12-31, 10-K 2024-09-30, 10-Q 2024-06-30

Data as of 2026-11-02